Clinical trial
Assessment of the Transfer of Using Levonorgestrel Intrauterine System (LNG IUS)…
NCT00185458 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00185458 |
|---|---|
| Title | Assessment of the Transfer of Using Levonorgestrel Intrauterine System (LNG IUS) as a Contraceptive to Using it as Part of Hormone Replacement Therapy (HRT). |
| Official title | A 60-month Non-comparative Study on Bleeding Profiles With Levonorgestrel Intrauterine System in Transition From Reproductive Age Contraception to Menopause Age Endometrial Protection During Estrogen Replacement Therapy. |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Menopause |
| Intervention type | Drug |
| Interventions | LNG IUS |
| Enrollment | 394 |
| Start date | May 1, 2000 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Sep 16, 2005 |
| Last update posted | Nov 27, 2013 |
| Countries | Belgium, Finland, Netherlands, United Kingdom |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: